$ 63.41 Billion growth in Monoclonal Antibodies Market 2021-2025 | Targeted therapeutic mechanism of action to boost growth | Technavio

NEW YORK, June 9, 2021 /PRNewswire/ -- Set to grow by USD 63.41 billion during 2021-2025, Technavio's latest market research report estimates the monoclonal antibodies market to register a CAGR of over 8%. With a focus on identifying dominant industry influencers, Technavio's reports present a detailed study by the way of synthesis, and summation of data from multiple sources. This report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

Monoclonal Antibodies Market by Application and Geography - Forecast and Analysis 2021-2025

Request a Free Sample to understand the scope of the report!

The market is concentrated, and the degree of concentration will accelerate during the forecast period. AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA are some of the major market participants. The targeted therapeutic mechanism of action will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments while maintaining their positions in the slow-growing segments.

Monoclonal Antibodies Market 2021-2025: Segmentation

Monoclonal Antibodies Market is segmented as below:

  • Application
    • Oncology
    • Autoimmune Disorders
    • Infectious Diseases
    • Other Applications
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR44342

Monoclonal Antibodies Market 2021-2025: Vendor Analysis and Scope
To help businesses improve their market position, the monoclonal antibodies market provides a detailed analysis of around 25 vendors operating in the market. Some of these vendors include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi SA.

The report also covers the following areas:

  • Monoclonal Antibodies Market size
  • Monoclonal Antibodies Market trends
  • Monoclonal Antibodies Market industry analysis

The introduction of low-priced biosimilar monoclonal antibodies is likely to emerge as one of the primary drivers of the market. However, the high cost of monoclonal antibodies may threaten the growth of the market.

Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

Related Reports on Health Care Include:

Global Anti-nuclear Antibody (ANA) Testing Market - Global anti-nuclear antibody (ANA) market is segmented by end-user (hospitals and clinical diagnostic laboratories) and geography (North America, Europe, Asia, and ROW). Request a Free Sample Report

Global Biologic Therapeutics Market - Global biologic therapeutics market is segmented by product (antibody therapeutics, vaccines, cell therapy, gene therapy, and other therapies), application (oncology, autoimmune and inflammatory diseases, hematology, and other applications), and geography (Asia, Europe, North America, and ROW).
Request a Free Sample Report

Monoclonal Antibodies Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will assist monoclonal antibodies market growth during the next five years
  • Estimation of the monoclonal antibodies market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the monoclonal antibodies market
  • Analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of monoclonal antibodies market vendors

Table of Contents:

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2020-2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Oncology - Market size and forecast 2020-2025
  • Autoimmune disorders - Market size and forecast 2020-2025
  • Infectious diseases - Market size and forecast 2020-2025
  • Other applications - Market size and forecast 2020-2025
  • Market opportunity by Application

Market Segmentation by Type

  • Segmentation by type of monoclonal antibodies

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive Scenario
  • Vendor Landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi


  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report: www.technavio.com/report/monoclonal-antibodies-market-industry-analysis

Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/-63-41-billion-growth-in-monoclonal-antibodies-market-2021-2025--targeted-therapeutic-mechanism-of-action-to-boost-growth--technavio-301308561.html

SOURCE Technavio

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.